Glycans in Diseases and Therapeutics


Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited


  • Glycomedicine
  • Transfusion medicine
  • Congenital disorders of glycosylation (CDG)
  • Cancer biomarkers
  • Cardiovascular diseases
  • Cardiac arrest
  • Cancer associated coagulopathies

Related Conference of Glycans in Diseases and Therapeutics

May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Glycans in Diseases and Therapeutics Conference Speakers